A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. A Study To Investigate GW274150Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. ...
A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Synovial Thickness and Vascularity of 28 Days Repeat Dosing of GW274150 or 7.5mg Prednisolone in RA Subjects. A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Investigate the Safety, Tole ...
A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tolerability, pharmacokinetics and effect on synovial thickness and vascularity of 28 days repeat dosing of GW274150 or 7.5mg prednisolone in RA subjects A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tole ...
A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tolerability, pharmacokinetics and effect on synovial thickness and vascularity of 28 days repeat dosing of GW274150 or 7.5mg prednisolone in RA subjects A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tole ...
Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)
An Open-label, Single Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of 90mg of GW274150 in Adult and Elderly RA Subjects. An Open-label, Single Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of 90m ...